Shanghai Henlius Biotech grants 4.13 million share options at HK$ 62.28 each

• Shanghai Henlius Biotech set new equity awards, granting 4,130,000 H-share options to 27 participants, grant date July 17, 2026.
• Options carry a nil grant price, exercise price HK$ 62.28; stock closed at HK$ 57.75 on the grant date.
• Grant includes 1,500,000 options to Jun Zhu; remaining options split across employees and service providers.
• Also granted 230,000 RSUs to 11 participants; nil grant price, vesting price RMB 1 per restricted share.
• Most awards vest over four years from July 17, 2027, with portions tied to annual performance targets or market-capitalization targets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Henlius Biotech Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260717-12248876), on July 17, 2026, and is solely responsible for the information contained therein.